Intellia Therapeutics, Inc. - NTLA

About Gravity Analytica
Recent News
- 09.23.2025 - Bernstein Healthcare Forum
- 09.04.2025 - Wells Fargo Health Care Conference
- 08.07.2025 - Intellia Therapeutics Second Quarter 2025 Earnings Conference Call
- 08.07.2025 - Intellia Therapeutics Second Quarter 2025 Earnings Conference Call
- 08.07.2025 - Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress
- 08.07.2025 - Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress
- 08.01.2025 - Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- 08.01.2025 - Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- 07.31.2025 - Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates
- 07.31.2025 - Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates
Recent Filings
- 08.07.2025 - EX-99.1 EX-99.1
- 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 08.07.2025 - 8-K Current report
- 07.25.2025 - 4 Statement of changes in beneficial ownership of securities
- 07.03.2025 - 4 Statement of changes in beneficial ownership of securities
- 07.03.2025 - 4 Statement of changes in beneficial ownership of securities
- 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.18.2025 - 4 Statement of changes in beneficial ownership of securities